Research, Science and Treatments

Genetics and the BAP1 Gene in Mesothelioma

BAP1 is the first gene discovered in mesothelioma. Not everyone has the mutated copy of this gene and, in fact, we are just embarking on trials to try to get a better handle on the incidence.
In germ line mutations (inherited mutation), the gene is thought to be extremely rare but has some interesting associations with […]


Complementary Cancer Therapies: Helpful or Hurtful?

Every year, consumers spend an estimated $40 billion on complementary and alternative medicine treatments and products, with hopes of miraculous cures, often unsupported by research or by science. Some consumers affected by life-threatening illnesses, including cancer, may approach the topic of supplements or alternative therapies as an added bonus without considering the side-effects or the […]


UPDATES FROM IMIG: Part 2, Thursday, September 13, 2012

In a talk concerning adjuvant radiation following EPP, it was stated that radiation oncologists who are inexperienced may not give as high a dose or may shy away from difficult areas.  It was felt to be important based upon lower local failure in centers with expertise in radiation oncology.  Concern was expressed about patients having […]


UPDATES FROM IMIG: Part 1 – Thursday, September 13

Dr. David Sugarbaker spoke about the effectiveness of surgery and some of the adjuvant therapies that can be used to clean up the surgical site or to combat recurrent disease. We heard about biologics, photodynamic therapy, and there will be sessions later today on intracavitary heated chemotherapy during surgery, and then more on staging, imaging, […]


Intro to iMig: iMig and the Meso Foundation

What is iMig?
In the next week and a half, you will be hearing a lot about the iMig meeting. This may leave you with a few questions, first one of which probably being “what is iMig?”
The International Mesothelioma Interest Group (iMig) is an independent international group of scientists and clinicians working to understand, cure and […]